Union Health Ministry allows import of Oxytocin API to manufacture drugs exclusively for export Medical Dialogues Team1 Nov 2021 6:50 PM ISTNew Delhi: Through a recent gazette notification, the Ministry of Health and Family Welfare has allowed the import of oxytocin as an Active...
Covishield re-vaccination after Covaxin: SC saids to wait for WHO decision MD Bureau31 Oct 2021 11:00 AM ISTNew Delhi: The Supreme Court on Friday said it will wait for the WHO's decision on indigenous vaccine Covaxin's recognition, before taking up a...
FIRST: Pfizer-BioNTech gets USFDA emergency use nod for COVID vaccine in kids aged 5 through 11 years old Ruchika Sharma30 Oct 2021 1:31 PM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced that the U.S. Food and Drug Administration (USFDA) has authorized for emergency use...
DCGI nod to new device-aided therapy for Parkinson's disease Medical Dialogues Team29 Oct 2021 5:50 PM ISTHyderabad:In a development, the Drug Controller General of India (DCGI) has granted approval for a new device-aided therapy for Parkinson's...
Merck to share molnupiravir formula with poor countries, enters agreement with MPP Ruchika Sharma28 Oct 2021 5:23 PM ISTGeneva: To ensure the affordable global access for molnupiravir, pharma giant Merck (MSD) has entered into a voluntary licencing...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
NPPA caps ceiling prices of 12 anti-diabetic drugs, Details Medical Dialogues Team26 Oct 2021 5:00 PM ISTTo make it possible for every Indian to afford medical treatment against diseases like diabetes, NPPA has initiated a successful step by fixing the...
CDSCO panel junks Novartis proposed clinical trial of oral treatment for C3 glomerulopathy Medical Dialogues Team25 Oct 2021 4:49 PM ISTNew Delhi: In a setback to pharma major Novartis, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization...
Novartis proposal to market Inclisiran with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team24 Oct 2021 11:30 AM ISTNew Delhi: Rejecting Novartis Healthcare's proposal to import and market Inclisiran Solution for Injection with a local clinical trial waiver,...
Bombay HC restrains firm from infringing Sun Pharma trademark Prolomet Medical Dialogues Team23 Oct 2021 5:54 PM ISTNew Delhi: The Bombay High Court has noted an ad-interim injunction restraining the Salud Care (India) Private from using trademark PROLOMEK or any...
Sun Pharma told to submit revised CT protocol for Ferric Pyrophosphate Citrate Solution Medical Dialogues Team22 Oct 2021 6:24 PM ISTNew Delhi: In response to the drug-major Sun Pharma Ltd's phase 3 protocol of Ferric Pyrophosphate Citrate Solution, the Subject Expert Committee...
Indian Pharma Market sees 13 percent growth in September sales: AIOCD-AWACS Report Medical Dialogues Team21 Oct 2021 5:51 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant growth of 13% at Total Sales Audit (TSA) and 11% at Secondary Sales...
